Abstract:Cysteine and glycine-rich protein 2 (Csrp2) has emerged as a key factor in controlling the phenotypic modulation of smooth muscle cells. The phenotypic transition of airway smooth muscle cells (ASMCs) is a pivotal step in developing airway remodeling during the onset of asthma. However, whether Csrp2 mediates the phenotypic transition of ASMCs in airway remodeling during asthma onset is undetermined. This work aimed to address the link between Csrp2 and the phenotypic transition of ASMCs evoked by platelet-derived growth factor (PDGF)-BB in vitro. The overexpression or silencing of Csrp2 in ASMCs was achieved through adenovirus-mediated gene transfer. The expression of mRNA was measured by quantitative real-time-PCR. Protein levels were determined through Western blot analysis. Cell proliferation was detected by EdU assay and Calcein AM assays. Cell cycle distribution was assessed via fluorescence-activated cell sorting assay. Cell migration was evaluated using the scratch-wound assay. The transcriptional activity of Yes-associated protein (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ) was measured using the luciferase reporter assay. A decline in Csrp2 level occurred in PDGF-BB-stimulated ASMCs. Increasing Csrp2 expression repressed the PDGF-BB-evoked proliferation and migration of ASMCs. Moreover, increasing Csrp2 expression impeded the phenotypic change of PDGF-BB-stimulated ASMCs from a contractile phenotype into a synthetic/proliferative phenotype. On the contrary, the opposite effects were observed in Csrp2-silenced ASMCs. The activity of YAP/TAZ was elevated in PDGF-BB-stimulated ASMCs, which was weakened by Csrp2 overexpression or enhanced by Csrp2 silencing. The YAP/TAZ activator could reverse Csrp2-overexpression-mediated suppression of the PDGF-BB-evoked phenotypic switching of ASMCs, while the YAP/TAZ suppressor could dimmish Csrp2-silencing-mediated enhancement on PDGF-BB-evoked phenotypic switching of ASMCs. In summary, Csrp2 serves as a determinant for the phenotypic switching of ASMCs. Increasing Csrp2 is able to impede PDGF-BB-evoked phenotypic change of ASMCs from a synthetic phenotype into a synthetic/proliferative phenotype through the effects on YAP/TAZ. This work implies that Csrp2 may be a key player in airway remodeling during the onset of asthma. This study reported that Csrp2 plays a crucial role in the phenotypic transition of ASMCs. Overexpression of Crsp2 repressed the phenotypic change of PDGF-BB-stimulated ASMCs from a contractile phenotype into a synthetic/proliferative phenotype through inhibition of YAP/TAZ. Given that the phenotypic transformation of ASMCs plays a critical role in the development of airway remodeling in asthma, the Crsp2-regulated YAP/TAZ pathway may represent a critical mechanism for the pathogenesis of asthma. Therefore, therapeutic approaches target and promote Csrp2 expression may have potential applications in treatment of asthma in the future.

Cylindromatosis (CYLD) Inhibits Streptococcus Pneumonia-Induced Plasminogen Activator Inhibitor-1 Expression Via Interacting with TRAF-6.

CCAAT/enhancer-binding Protein Δ is a Critical Mediator of Lipopolysaccharide-Induced Acute Lung Injury.

IgG Immune Complex-Induced Acute Lung Injury is Ameliorated by Camp Via Down-Regulation of C/EBP- and AP-1-mediated Transcriptions.

Tumor Suppressor CYLD Regulates Acute Lung Injury in Lethal Streptococcus Pneumoniae Infections

CYLD Negatively Regulates Nontypeable Haemophilus Influenzae-Induced IL-8 Expression Via Phosphatase MKP-1-Dependent Inhibition of ERK

Plasminogen Activator Inhibitor Type-1 Deficiency Exaggerates Lps-Induced Acute Lung Injury Through Enhancing Toll-Like Receptor 4 Signaling Pathway

Plasminogen Activator Inhibitor-1 Regulates LPS-Induced TLR4/MD-2 Pathway Activation and Inflammation in Alveolar Macrophages

Airway Epithelial Cgas Inhibits LPS-induced Acute Lung Injury Through CREB Signaling

Plasminogen Activator Inhibitor 1 Promotes Immunosuppression in Human Non-Small Cell Lung Cancers by Enhancing TGF-Β1 Expression in Macrophage

Critical Roles of PAI-1 in Lipopolysaccharide-Induced Acute Lung Injury.

CYLD Negatively Regulates Transforming Growth Factor-Β-signalling Via Deubiquitinating Akt

TRAF6 Suppresses the Development of Pulmonary Fibrosis by Attenuating the Activation of Fibroblasts

Effect and mechanism of phospholipid scramblase 4 (PLSCR4) on lipopolysaccharide (LPS)-induced injury to human pulmonary microvascular endothelial cells

Protectin Conjugates in Tissue Regeneration 1 Inhibits Macrophage Pyroptosis by Restricting NLRP3 Inflammasome Assembly to Mitigate Sepsis via the cAMP-PKA Pathway

PLD2 deletion alleviates disruption of tight junctions in sepsis-induced ALI by regulating PA/STAT3 phosphorylation pathway

IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome

CTRP6 promotes the macrophage inflammatory response, and its deficiency attenuates LPS-induced inflammation

Circ_0138959/miR-495-3p/TRAF6 axis regulates proliferation, wound healing and osteoblastic differentiation of periodontal ligament cells in periodontitis

Pseudomonas aeruginosa pyocyanin modulates mucin glycosylation with sialyl-Lewis(x) to increase binding to airway epithelial cells

Cysteine and Glycine-Rich Protein 2 Retards Platelet-Derived Growth Factor-Bb-evoked Phenotypic Transition of Airway Smooth Muscle Cells by Decreasing YAP/TAZ Activity.

Claudin-1 Regulates Pulmonary Artery Smooth Muscle Cell Proliferation Through the Activation of ERK1/2.